Advertisement

Reply to “Crashing NASH in Patients Listed for Bariatric Surgery”

  • Geraldine J. OoiEmail author
  • Paul R. Burton
  • William W. Kemp
  • Stuart K. Roberts
  • Wendy A. Brown
Letter to Editor/LED Reply
  • 17 Downloads

Notes

Compliance with Ethical Standards

Disclosures

Geraldine Ooi, Paul Burton, and Wendy Brown report being affiliated with The Centre for Obesity Research and Education. The center has received funding for research purposes from Allergan and Apollo Endosurgery, the manufacturers of the LapBand™. The grant is not tied to any specific research project, and neither Allergan nor Apollo Endosurgery have control of the protocol, analysis, and reporting of any studies. The center also receives a grant from Applied Medical towards educational programs.

Wendy Brown reports financial support for a bariatric surgery registry from the Commonwealth of Australia, Apollo Endosurgery, Covidien, Johnson and Johnson, Gore and Applied Medical. Since initial submission of this paper, she has also received a speaker’s honorarium from Merck Sharpe and Dohme and a speaker’s honorarium and fees from participation in a scientific advisory board from Novo Nordisk. The bariatric registry and the honorariums are outside of the submitted work.

Geraldine Ooi reports scholarships from the National Health and Medical Research Council and the Royal Australasian College of Surgeons.

The remaining authors have no other disclosures or conflicts of interest.

[Authors] report being affiliated with [Affiliation]. [Affiliation] has received funding for research purposes from Allergan and Apollo Endosurgery, the manufacturers of the LapBand™. The grant is not tied to any specific research project, and neither Allergan nor Apollo Endosurgery have control of the protocol, analysis and reporting of any studies. [Affiliation] also receives a grant from Applied Medical towards educational programs.

[Author] reports financial support for a bariatric surgery registry from the Commonwealth of Australia, Apollo Endosurgery, Covidien, Johnson and Johnson, Gore and Applied Medical. Since initial submission of this paper, they have also received a speaker’s honorarium from Merck Sharpe and Dohme and a speaker’s honorarium and fees from participation in a scientific advisory board from Novo Nordisk. The bariatric registry and the honorariums are outside of the submitted work.

[Author] reports scholarships from the National Health and Medical Research Council and the Royal Australasian College of Surgeons.

The remaining authors have no other disclosures or conflicts of interest.

References

  1. 1.
    Colles SL, Dixon JB, Marks P, et al. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal faty by serial imaging. Am J Clin Nutr. 2006;84(2):304–11.CrossRefPubMedGoogle Scholar
  2. 2.
    Edholm D, Kullberg J, Haenni A, et al. Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg. 2011;21(3):345–50.CrossRefPubMedGoogle Scholar
  3. 3.
    Castera L. Noninvasive evaluation of nonalcoholic fatty liver disease. Semin Liver Dis. 2015;35:291–303.CrossRefPubMedGoogle Scholar
  4. 4.
    Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149:379–88.CrossRefPubMedGoogle Scholar
  5. 5.
    Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367–78.CrossRefPubMedGoogle Scholar
  6. 6.
    Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy - AASLD position paper. Hepatology. 2009;49(3):1017–44.CrossRefPubMedGoogle Scholar
  7. 7.
    Saris WHM. Very low calorie diets and sustained weight loss. Obes Res. 2001;9(Suppl 4):295S–301S.CrossRefPubMedGoogle Scholar
  8. 8.
    Ooi GJ, Earnest A, Kemp W, et al. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity. Int J Obes. 2018;42(11):1900–11.CrossRefGoogle Scholar
  9. 9.
    Ooi GJ, Mgaieth S, Eslick GD, et al. Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese. Obes Rev. 2017;19(2):281–94.CrossRefPubMedGoogle Scholar
  10. 10.
    Merriman RB, Ferrell LD, Patti MG, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology. 2006;44:874–80.CrossRefPubMedGoogle Scholar
  11. 11.
    Ooi GJ, Burton PR, Bayliss J, et al. Effect of body mass index, metabolic health and adipose tissue inflammation on the severity of nonalcoholic fatty liver disease in bariatric surgical patients: a prospective study. Obes Surg. 2018.  https://doi.org/10.1007/s11695-018-3479-2

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Centre for Obesity Research and Education, Central Clinical SchoolMonash UniversityMelbourneAustralia
  2. 2.Department of General SurgeryThe Alfred HospitalMelbourneAustralia
  3. 3.Department of HepatologyThe Alfred HospitalMelbourneAustralia

Personalised recommendations